New rapid antigen test for diagnosis of pneumococcal meningitis.
Conventional diagnostic methods for bacterial meningitis are frequently not rapid or sensitive enough to guide initial antimicrobial therapy. Streptococcus pneumoniae is the most frequent and severe cause of community-acquired bacterial meningitis and treatment is complicated by the increasing prevalence of antimicrobial resistance to third-generation cephalosporins. We used a new rapid antigen test in the cerebrospinal fluid and urine of patients with suspected bacterial meningitis, and found it to be highly sensitive and specific for the detection of pneumococci. This test might help guide initial therapy for bacterial meningitis according to the local rates of pneumococcal antimicrobial resistance.
Marcos
M A
MA
Martínez
E
E
Almela
M
M
Mensa
J
J
Jiménez de Anta
M T
MT
D000328:Adult; D002439:Cefotaxime / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D008586:Meningitis, Pneumococcal / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D008826:Microbial Sensitivity Tests; D010406:Penicillins / Q000008:administration & dosage; D011135:Polysaccharides, Bacterial / Q000032:analysis*; D011237:Predictive Value of Tests
D010406:Penicillins; D011135:Polysaccharides, Bacterial; C027158:polysaccharide C-substance (Streptococcus); D002439:Cefotaxime